A Randomized, Double-Blinded, Controlled Trial Evaluating Recombinant Human Platelet-Derived Growth Factor B (rhPDGF-BB)-Enhanced Wound Matrix in the Reconstruction of Full-Thickness Head or Neck Defects Following Skin Cancer Excision
Latest Information Update: 16 Oct 2024
At a glance
- Drugs GEM 21S (Primary)
- Indications Bone disorders
- Focus Therapeutic Use
- 16 Oct 2024 New trial record